Start Date
20-5-2011 10:45 AM
End Date
20-5-2011 12:15 PM
Description
The objective of this study was to compare the effectiveness of abatacept to anti-TNFs using the following:
- Change in disease activity based on the Clinical Disease Activity Index
- (CDAI) Achievement of remission based on the CDAI
Among this small sample of RA patients in a real-world setting, treatment with abatacept was not associated with any differences in response or remission rates from those seen with anti-TNFs based on mean change in CDAI and achievement of CDAI remission. This study suggests similar effectiveness of abatacept and anti-TNFs in biologic naïve RA patients. Further research with a larger sample size is needed to confirm these findings.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License.
Targeted Therapies in RA: Real World Comparative Effectiveness Research
The objective of this study was to compare the effectiveness of abatacept to anti-TNFs using the following:
- Change in disease activity based on the Clinical Disease Activity Index
- (CDAI) Achievement of remission based on the CDAI
Among this small sample of RA patients in a real-world setting, treatment with abatacept was not associated with any differences in response or remission rates from those seen with anti-TNFs based on mean change in CDAI and achievement of CDAI remission. This study suggests similar effectiveness of abatacept and anti-TNFs in biologic naïve RA patients. Further research with a larger sample size is needed to confirm these findings.